Literature DB >> 12200806

Health care resource utilization and the impact of anemia management in patients with chronic kidney disease.

Roger London1, Amy Solis, George A Goldberg, Sally Wade, Seonyoung Ryu.   

Abstract

BACKGROUND: Limited information exists on resource utilization patterns and overall patient management of chronic kidney disease (CKD) before the initiation of dialysis therapy.
METHODS: A retrospective claims analysis from January 1997 to December 1999 was conducted using a managed care database on 1,936 incident dialysis patients, examining the 12 months preceding dialysis initiation to evaluate whether managed care patients with CKD are receiving expected interventions and appropriate management of CKD.
RESULTS: Mean age was 66.8 years, 46% were women, 91.2% had claims for facility services, 97.6% had claims for professional services, and 95.7% had claims for outpatient pharmacy, with mean costs per patient of $26,204, $9,623, and $1,503, respectively. Sixty-two percent of patients were hospitalized, averaging 1.3 admissions annually ($14,818/admission; average, 7.8 d/admission). Despite high overall resource use, treatments for preparation for dialysis therapy, appropriate tests, and nutritional supplements (eg, phosphate binders, B-complex combinations, and vitamins with iron) were administered infrequently. Comorbid conditions, such as anemia (47.4%) and diabetes (53%), were appropriately addressed with erythropoietin (10.5%) and angiotensin-converting enzyme inhibitors (38%) in only a minority of cases. In preparation for dialysis therapy, only 20.8% underwent a vascular access procedure.
CONCLUSION: Although patients consumed significant amounts of resources during the 12 months before dialysis initiation, many were not using expected resources for the appropriate management of CKD. A number of opportunities exist to improve predialysis care through better management of these conditions. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12200806     DOI: 10.1053/ajkd.2002.34912

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Renal function and healthcare costs in patients with polycystic kidney disease.

Authors:  Krista L Lentine; Huiling Xiao; Gerardo Machnicki; Adrian Gheorghian; Mark A Schnitzler
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Reducing the Economic and Clinical Burden Of CKD in the Managed Care Setting.

Authors:  Samir H Mody
Journal:  Biotechnol Healthc       Date:  2004-10

3.  Pharmaceutical cost distribution in childhood chronic kidney disease.

Authors:  Janis M Dionne; Kelvin Lou; Lee Er; Kathleen Collin; Colin T White
Journal:  Pediatr Nephrol       Date:  2012-05-01       Impact factor: 3.714

Review 4.  Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease.

Authors:  Monique P Curran; Paul L McCormack
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review.

Authors:  Marie D Philipneri; Lisa A Rocca Rey; Mark A Schnitzler; Kevin C Abbott; Daniel C Brennan; Steven K Takemoto; Paula M Buchanan; Thomas E Burroughs; Lisa M Willoughby; Krista L Lentine
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

6.  An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study.

Authors:  Jan-Christoph Galle; Kathleen Claes; Istvan Kiss; Christopher G Winearls; Hans Herlitz; Alain Guerin; Salvatore Di Giulio; Michael G Suranyi; Ian Bridges; Janet Addison; Mourad Farouk
Journal:  Nephrol Dial Transplant       Date:  2011-12-02       Impact factor: 5.992

7.  Emergency department use by patients with end-stage renal disease in the United States.

Authors:  Ningyuan Wang; Jiao Pei; Hui Fan; Yaseen Ali; Anna Prushinskaya; Jian Zhao; Xingyu Zhang
Journal:  BMC Emerg Med       Date:  2021-03-02

8.  Predictors of anemia in a multi-ethnic chronic kidney disease population: a case-control study.

Authors:  Bing Chang Vincent Lau; Kheng Yong Ong; Chun Wei Yap; Anantharaman Vathsala; Priscilla How
Journal:  Springerplus       Date:  2015-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.